Group O HIV-1, fragments of such viruses, and uses thereof

US6030769A · kind A · utility

Assignees

• Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
• ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS (APHP) · FR

Inventors

• Francois Simon · Paris, FR
• Sentob Saragosti · Billancourt, FR
• Ibtissam Loussert-Ajaka · Sartrouville, FR
• Thoai-Duong Ly · Rueil-Malmaison, FR
• Marie-Laure Chaix-Baudier · Paris, FR

Key dates

• Filing date: Dec 1, 1997
• Grant date: Feb 29, 2000
• Expiry date: Dec 1, 2017

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2740/16122
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Group HIV-1 retrovirus strains, particularly the strains known as BCF02, BCF01, BCF06, BCF07, BCF08, BCF11, BCF03, BCF09, BCF12, BCF13 and BCF14, fragments of said retroviruses, and the uses thereof as a diagnostic reagent and as an immunogen, are disclosed.